卡介苗膀胱内灌注治疗膀胱癌期间白细胞介素-2的产生
Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer.
作者信息
Ratliff T L, Haaff E O, Catalona W J
出版信息
Clin Immunol Immunopathol. 1986 Aug;40(2):375-9. doi: 10.1016/0090-1229(86)90043-7.
PMID:3487405
Abstract
Interleukin-2 (IL-2) was detected in urine but not serum of patients receiving intravesical bacille Calmette-Guerin (BCG) therapy for bladder cancer. IL-2 activity was neutralized by anti-IL-2 antibody. No IL-2 was detected in urine before BCG therapy or from control donors. BCG-induced urine IL-2 peaked 4-8 hr after treatment but was rarely observed after 24 hr. The presence of BCG-induced lymphokines may be associated with antitumor activity.
摘要
在接受卡介苗（BCG）膀胱灌注治疗膀胱癌的患者尿液中检测到白细胞介素-2（IL-2），但血清中未检测到。IL-2活性可被抗IL-2抗体中和。在BCG治疗前的尿液或对照供体的尿液中未检测到IL-2。BCG诱导的尿液IL-2在治疗后4-8小时达到峰值，但24小时后很少观察到。BCG诱导的淋巴因子的存在可能与抗肿瘤活性有关。
Zotero 插件